Publications:

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.

Nature

Yao, Zhan Z; Yaeger, Rona R; Rodrik-Outmezguine, Vanessa S VS; Tao, Anthony A; Torres, Neilawattie M NM; Chang, Matthew T MT; Drosten, Matthias M; Zhao, Huiyong H; Cecchi, Fabiola F; Hembrough, Todd T; Michels, Judith J; Baumert, Hervé H; Miles, Linde L; Campbell, Naomi M NM; de Stanchina, Elisa E; Solit, David B DB; Barbacid, Mariano M; Taylor, Barry S BS; Rosen, Neal N

Publication Date: 2017-08-10

Variant appearance in text: RB1: I517S

PubMed Link: 28783719

Variant Present in the following documents:

• Main text

View BVdb publication page